ncRNA Drives Trastuzumab Resistance in HER2 Tumors
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...
Across urban landscapes in the United States, the lingering shadows of discriminatory housing policies from nearly a century ago continue ...
A groundbreaking approach to address metastatic breast cancer, a particularly aggressive form of the disease, is emerging from the University ...
In a groundbreaking study focusing on breast cancer, a cohort of Black women residing in disadvantaged neighborhoods has revealed unsettling ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine